We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Supernus Pharmaceuticals Inc | NASDAQ:SUPN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.56 | 1.85% | 30.83 | 18.44 | 42.01 | 30.91 | 30.00 | 30.74 | 362,428 | 01:00:00 |
|
Delaware
|
001-35518
|
20-2590184
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|||
1550 East Gude Drive
|
Rockville
|
MD
|
20850
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
Common Stock, $0.001 par value per share
|
SUPN
|
The Nasdaq Global Market
|
|
Number
|
|
Description
|
|
|
99.1
|
|
|
Attached
|
|
|
|
|
|
|
99.2
|
|
|
Attached
|
|
SUPERNUS PHARMACEUTICALS, INC.
|
|
|
|
|
DATED: November 12, 2019
|
By:
|
/s/ Gregory S. Patrick
|
|
|
Gregory S. Patrick
|
|
|
Senior Vice-President and Chief Financial Officer
|
1 Year Supernus Pharmaceuticals Chart |
1 Month Supernus Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions